Match!
Yan-Guang Li
Peking University
CardiologyAtrial fibrillationStrokeDiabetes mellitusMedicine
13Publications
4H-index
58Citations
What is this?
Publications 16
Newest
#1Jakub Gumprecht (University of Liverpool)H-Index: 2
#2Magdalena Domek (University of Liverpool)H-Index: 1
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 143
view all 9 authors...
Atrial fibrillation (AF) is associated with substantially increased risk of cardiovascular events and overall mortality. The Atrial fibrillation Better Care (A—Avoid stroke, B—Better symptom management, C—Cardiovascular and comorbidity risk management) pathway provides a simple and comprehensive approach for integrated AF therapy. This study’s goals were to evaluate the ABC pathway compliance and determine the main gaps in AF management in the Middle East population, and to assess the impact of ...
Source
#1Magdalena Domek (University of Liverpool)H-Index: 1
#2Yan-Guang Li (PKU: Peking University)H-Index: 4
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 143
view all 10 authors...
Abstract Background Atrial fibrillation (AF) poses a great risk of mortality, especially when associated with diabetes mellitus (DM). Objectives We aimed to investigate the rate and risk factors for mortality among AF patients with and without DM in the population from the Middle East where it has never been investigated before. Methods We analyzed the Gulf-SAFE registry, involving patients with nonvalvular AF from the Middle East, for one-year all-cause mortality. The predictive capability of t...
Source
#1Daniele Pastori (University of Birmingham)H-Index: 23
#2Kazuo Miyazawa (University of Birmingham)H-Index: 3
Last. Gregory Y.H. Lip (University of Birmingham)H-Index: 143
view all 7 authors...
Background Patients with atrial high-rate episodes (AHREs) are at higher risk of thromboembolic events and mortality. The risk of major adverse cardiovascular events (MACE) in these patients is unknown.
2 CitationsSource
#1Yan-Guang Li (University of Birmingham)H-Index: 4
#2Kazuo Miyazawa (University of Birmingham)H-Index: 3
Last. Gregory Y.H. Lip (University of Birmingham)H-Index: 143
view all 6 authors...
Abstract Background Patients with cardiac implantable electronic device (CIED) developing atrial high-rate episodes (AHRE) have a significant risk of thromboembolic events (TEs), but risk factors have been scarcely investigated. Objectives To analyze risk factors for TEs in a contemporary cohort of patients with CIED. Methods Consecutive non-AF patients without anticoagulation at baseline were followed up after the CIED implantation. The role of newly-developed AHRE and other risk factors for TE...
2 CitationsSource
#1Kazuo Miyazawa (University of Birmingham)H-Index: 3
#2Daniele Pastori (Sapienza University of Rome)H-Index: 23
Last. Gregory Y.H. Lip (University of Birmingham)H-Index: 143
view all 7 authors...
Background Atrial high rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs) are associated with an increased risk of stroke. However, the impact of AHRE on improving stroke risk stratification scheme remains uncertain.
3 CitationsSource
Abstract Stroke prevention is the cornerstone of the management of patients with atrial fibrillation (AF). Individual stroke risk stratification is generally the first step of deciding whether oral anticoagulation (OAC) will benefit patients with AF. Given that existing approaches to the prediction of ‘high risk' subjects are of limited value, the initial focus should be the identification of ‘low-risk' patients who do not need antithrombotic therapy. For this, the CHA 2 DS 2 -VASc score (conges...
3 CitationsSource
Background The C2HEST score (coronary artery disease or chronic obstructive pulmonary disease [1 point each]; hypertension [1 point]; elderly [age ≥75 years, 2 points]; systolic heart failure [2 po...
Source
#1Yan-Guang Li (University of Birmingham)H-Index: 4
#2Kazuo Miyazawa (University of Birmingham)H-Index: 3
Last. Gregory Y.H. Lip (University of Birmingham)H-Index: 143
view all 7 authors...
Abstract Background Differences exist in oral anticoagulation (OAC) use between different populations with atrial fibrillation (AF), which may be associated with varying outcomes. Purpose We aimed to provide patient level comparisons of clinical characteristics, OAC use, and one-year risks of stroke and mortality among two cohorts of patients with AF, from the United Kingdom (UK) and Middle East (ME). Methods The clinical characteristics, prescription of OAC, one-year risk of stroke and mortalit...
Source
#1Kazuo Miyazawa (University of Birmingham)H-Index: 3
#2Yan-Guang Li (Chinese PLA General Hospital)H-Index: 4
Last. Gregory Y.H. Lip (University of Birmingham)H-Index: 143
view all 7 authors...
Abstract Background Anticoagulation therapy in patients with atrial fibrillation (AF) is well established as effective thromboprophylaxis. However, AF patients with prior stroke are often treated with suboptimal antithrombotic treatment (ATT). In the present study, we investigated clinical characteristics and outcomes in AF patients with versus without prior stoke, in relation to guideline adherence in ATT. Methods We used data from the Gulf SAFE registry, which included patients with AF who pre...
2 CitationsSource
#1Yan-Guang Li (University of Birmingham)H-Index: 4
#2Marco Borgi (University of Birmingham)H-Index: 1
Last. Gregory Y.H. LipH-Index: 143
view all 3 authors...
Source
12